Table 2.
Summary of virus detection cases.
| Case | Age | Sex | Disease type | Luminex xTAG-RVP | BioFire FA-RP | BMI | Smoking status | Brinkman index | OCS | % FVC | FEV1.0 | % FEV1.0% | % FEV 1.0% | DLCO/VA | % DLCO/VA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 73 | M | CPFE | RSV | – | 19.7 | Ex | 430 | Prednisolone 10 mg/day | 102.8 | 3.22 | 97.2 | 125.3 | 1.58 | 35.9 |
| 2 | 79 | F | NSIP | influenza A RSV | RSV | 30.6 | Never | 0 | Prednisolone 10 mg/day | 44.6 | 0.70 | 80.4 | 47 | 3.59 | 86.2 |
| 3 | 77 | M | PPFE | influenza A rhino/enterovirus | – | 21.2 | Ex | 400 | – | 76.9 | 2.72 | 88.8 | 85 | 3.86 | 90.5 |
M, male; F, female; CPFE, combined pulmonary fibrosis and emphysema; NSIP, nonspecific interstitial pneumonia; PPFE, pleuroparenchymal fibroelastosis; xTAG-RVP, xTAG respiratory viral panel v2 RUO; FA-RP, FilmArray respiratory panel; RSV, respiratory syncytial virus; OCS, oral corticosteroid; FVC, forced vital capacity; FEV1.0, forced expiratory volume in 1 s; DLCO, diffusing capacity of carbon monoxide; DLCO/VA, DLCO corrected for alveolar volume.